{"id":1007363,"date":"2026-10-01T07:41:10","date_gmt":"2026-10-01T11:41:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/"},"modified":"2026-10-01T07:41:10","modified_gmt":"2026-10-01T11:41:10","slug":"fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/","title":{"rendered":"Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN DIEGO, Oct.  01, 2026  (GLOBE NEWSWIRE) &#8212; Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in the following investor conferences in the fourth quarter of 2026.<\/p>\n<p>\n        <strong>2026 Jefferies Global Healthcare Conference<\/strong>\n      <\/p>\n<p>Location: London, UK<\/p>\n<p>Date: November 16<sup>th<\/sup> \u2013 19<sup>th<\/sup> \u00a0\u00a0\u00a0<\/p>\n<p>\n        <strong>Piper Sandler 38<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Healthcare Conference <\/strong>\n      <\/p>\n<p>Location: New York, NY<\/p>\n<p>Date: December 1<sup>st<\/sup> \u2013 3<sup>rd<\/sup>\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p>The Company may participate in a presentation or a fireside chat at these conferences. When available, a live webcast will be accessible under \u201cEvents &amp; Presentations\u201d on the Investors section of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nEh_w4SlldWm5KLqWWjxhbUbow8nLKvy56SLlpKWEHQjfHuMYbXDZ5Go_1IRcHWIYCZgMF3VJ_-AE5ZHeMgpwvrvO5RxwJljahi-m5UfvroPxz6eoQYNGQCrWLtYNJgY4--NdXaseeCACmbDJEtWq0leUywhfq0ioVhsULNW6Zfdi9MZeaXnL6uBDrN0l7KqqucuhNoyP0Qm_Bam0btCnEPMEAT9syZBkTvju81I-zMVdnwHKMKs7XzHp1P4Gb1-6nsFbE2mX5TD4WP3w_PGRCJqbFGMq95hr-IbERrtJW5O-TvrcTdcwiNHCdH4ious2BtGm_sJCZQRRdUY-PiPSU6Wu94_lhD-BkVNpzRbQmnHEqbEMwBDlreN7DL5_dCcBqyYfsm-FkV5qk6ufYr7fvC95aqmkGj3mbz4a6KUO6XpgCgay5oisuEaWw_4fMD9JGwG1Pshqig3OOfEoTxRFKG7wuseZJqGwbHEBbsBxtvY3UeeKfdflWrmtK32KcQaglGr0HH_McyOn-1Nq3sVbavlqoCvzIxv8mRbajYkgtxmbTUGrEjOCtHR_mBL588uruNmhzh_K_vGN5ze1FJeeAoTTGm_LWNdbBnVjIHSZjEFWuAOr6RUBV_lswZ8oziHyy_M3gbPTwJwLEctrxf0ogUNzqfHy-WslccSbjNLFb1k107QPg4ooaksIYUTfo395T8TMlkLK7PqRDpi5ql_JH4rj4rC2MWOtMLUjGN9Fps48AXsZgvJG8MCkN3PFVCyWN1A0SX448EM8e3VqWAl--xMnE5xtK8U_y-SNYP3K3wAh7yirzOk1DOe32vJHgu3fdrJzJtbpdIO_OfY3i7wpyFiXOUxjyA3fQYxZsyrPHezbizmm56OSkDq9K437AkD\" rel=\"nofollow\" target=\"_blank\">www.fatetherapeutics.com<\/a>. An archived replay of the webcast will be available for 30 days following the event.<\/p>\n<p>\n        <strong>About\u00a0Fate Therapeutics, Inc.<\/strong><\/p>\n<p>Fate Therapeutics\u00a0is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered master iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company\u2019s pipeline includes iPSC-derived T-cell and natural killer (NK) cell product candidates, which are selectively designed, incorporate novel synthetic controls of cell function, and are intended to deliver multiple therapeutic mechanisms to patients.\u00a0Fate Therapeutics\u00a0is headquartered in\u00a0San Diego, CA.\u00a0For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nEh_w4SlldWm5KLqWWjxhbUbow8nLKvy56SLlpKWEHS9zRulKpa5_6Ca6QUt7Bx4zpfm7xQnrafPfeIoKVoRU6I_LWZAsoSVfODHdP53Monq7ysART6RUAo8aUBfIZBczPspuGlTk_knmcor_s0lGTsISQ0N8JNDpGdzgquIm8tUZed0JUhnAmC1N43I4SCAZVFvwJw5B5PLkuVQFBlT5pwD4Ppbpj6cfeU1ZDLtPdn3qBsy6xnatiKDfcChsoIfcADpiX4CO_UfNw7kOg57rRcNkGwLgcW4fpI_OsDpZJgziUjSqWSh3Q3ghE10mBq3GzOv0xSI1vcoKDPfKGSyuI4lQZ0zFIGVxMYR_ysq8aoAKLNDacPhIAu-xph0PhpSNbG_kNsVft7BadpIwwcSHeykxUaFHEbreprl7sPr98pb4Pa3DzwjU5Yg8b6iJOLl8M7La4T5PRA4HQM_ocgJc3eHaUHFc9cB4mDkNpEhIKnVBzksJdq-_iGbRWnJV0MJ\" rel=\"nofollow\" target=\"_blank\">www.fatetherapeutics.com<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>Ryan Douglas<br \/>Fate Therapeutics, Inc.<br \/>IR@fatetherapeutics.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNzU2MSM3ODczNDczIzIwMDQyMDE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTY1NTM5YWItZjI0NC00MDU3LWI5YjUtYmI0ZWMwN2U0NTA4LTEwMTU3NzQtMjAyNi0xMC0wMS1lbg==\/tiny\/Fate-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) &#8212; Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in the following investor conferences in the fourth quarter of 2026. 2026 Jefferies Global Healthcare Conference Location: London, UK Date: November 16th \u2013 19th \u00a0\u00a0\u00a0 Piper Sandler 38 th Annual Healthcare Conference Location: New York, NY Date: December 1st \u2013 3rd\u00a0\u00a0\u00a0\u00a0\u00a0 The Company may participate in a presentation or a fireside chat at these conferences. When available, a live webcast will be accessible under \u201cEvents &amp; Presentations\u201d on the Investors section of the Company\u2019s website at\u00a0www.fatetherapeutics.com. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1007363","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) &#8212; Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in the following investor conferences in the fourth quarter of 2026. 2026 Jefferies Global Healthcare Conference Location: London, UK Date: November 16th \u2013 19th \u00a0\u00a0\u00a0 Piper Sandler 38 th Annual Healthcare Conference Location: New York, NY Date: December 1st \u2013 3rd\u00a0\u00a0\u00a0\u00a0\u00a0 The Company may participate in a presentation or a fireside chat at these conferences. When available, a live webcast will be accessible under \u201cEvents &amp; Presentations\u201d on the Investors section of the Company\u2019s website at\u00a0www.fatetherapeutics.com. &hellip; Continue reading &quot;Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-01T11:41:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNzU2MSM3ODczNDczIzIwMDQyMDE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences\",\"datePublished\":\"2026-10-01T11:41:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\\\/\"},\"wordCount\":263,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNzU2MSM3ODczNDczIzIwMDQyMDE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\\\/\",\"name\":\"Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNzU2MSM3ODczNDczIzIwMDQyMDE=\",\"datePublished\":\"2026-10-01T11:41:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNzU2MSM3ODczNDczIzIwMDQyMDE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNzU2MSM3ODczNDczIzIwMDQyMDE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences - Market Newsdesk","og_description":"SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) &#8212; Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in the following investor conferences in the fourth quarter of 2026. 2026 Jefferies Global Healthcare Conference Location: London, UK Date: November 16th \u2013 19th \u00a0\u00a0\u00a0 Piper Sandler 38 th Annual Healthcare Conference Location: New York, NY Date: December 1st \u2013 3rd\u00a0\u00a0\u00a0\u00a0\u00a0 The Company may participate in a presentation or a fireside chat at these conferences. When available, a live webcast will be accessible under \u201cEvents &amp; Presentations\u201d on the Investors section of the Company\u2019s website at\u00a0www.fatetherapeutics.com. &hellip; Continue reading \"Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-01T11:41:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNzU2MSM3ODczNDczIzIwMDQyMDE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences","datePublished":"2026-10-01T11:41:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/"},"wordCount":263,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNzU2MSM3ODczNDczIzIwMDQyMDE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/","name":"Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNzU2MSM3ODczNDczIzIwMDQyMDE=","datePublished":"2026-10-01T11:41:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNzU2MSM3ODczNDczIzIwMDQyMDE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNzU2MSM3ODczNDczIzIwMDQyMDE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1007363","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1007363"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1007363\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1007363"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1007363"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1007363"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}